Tumor Microenvironment and Its Role in Cancer Progression: An Integrative Review.

The tumor microenvironment (TME) plays a crucial role in cancer progression, metastasis, immune evasion, and treatment resistance. However, the current literature often studies its components separately. This review offers an integrated view of the dynamic interactions among fibroblasts, immune and vascular cells, the extracellular matrix, cytokines, exosomes, and microbiota within the TME. It discusses classical mechanisms such as epithelial-mesenchymal transition, stromal remodeling, and metabolic rewiring alongside emerging paradigms like microbiome-driven immunomodulation and exosome-mediated therapy resistance. Spatial heterogeneity and the temporal evolution of the tumor niche are examined using recent advances in single-cell and spatial transcriptomics, 3D bioprinting, and patient-derived organoid models. Key findings emphasize the microbiome's influence on immune responses and the role of exosomes in transferring resistance traits and regulating intercellular signaling. By connecting molecular insights with clinical perspectives, the review explores translational strategies targeting the TME, including checkpoint inhibitors, stromal modulators, anti-angiogenic agents, and engineered CAR-T therapies. This comprehensive view highlights the importance of considering cancer as a complex, evolving ecosystem rather than just a cell-autonomous disease and provides a foundational framework for precision oncology approaches aimed at disrupting harmful TME interactions to improve therapeutic effectiveness and patient outcomes.